Shanghai MicroPort EP MedTech Co., Ltd. (SHA:688351)
China · Delayed Price · Currency is CNY 16.62
-0.68 (-3.93%)
At close: Sep 11, 2026
SHA:688351 Income Statement
Financials in millions CNY. Fiscal year is January - December.
Millions CNY. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Operating Revenue | 507.94 | 452.41 | 406.88 | 319.99 | 257.52 | 189.41 |
Other Revenue | 8.08 | 12.12 | 6.28 | 9.21 | 2.81 | 0.62 |
| 516.03 | 464.53 | 413.17 | 329.19 | 260.32 | 190.03 | |
Revenue Growth | 17.67% | 12.43% | 25.51% | 26.46% | 36.99% | 34.50% |
Cost of Revenue | 229.3 | 198.59 | 173.49 | 120.66 | 81.13 | 53.09 |
Gross Profit | 286.72 | 265.94 | 239.68 | 208.54 | 179.19 | 136.94 |
Selling, General & Admin | 194.08 | 176.5 | 153.5 | 150.15 | 117.19 | 104.61 |
Research & Development | 70.04 | 64.08 | 77.4 | 91.31 | 76.93 | 63.01 |
Other Operating Expenses | -4.21 | 3.53 | 3.13 | 2.2 | 1.26 | 0.97 |
Operating Expenses | 260.71 | 244.96 | 235.29 | 245.02 | 196.19 | 168.8 |
Operating Income | 26.01 | 20.98 | 4.38 | -36.48 | -16.99 | -31.86 |
Interest Expense | -0.11 | -0.3 | -0.89 | -1.27 | -0.72 | -0.46 |
Interest & Investment Income | 28.8 | 11.92 | 13.09 | 16.97 | 9.32 | 7.66 |
Currency Exchange Gain (Loss) | -2.81 | -0.61 | -0.02 | 0.56 | -1.21 | -0.23 |
Other Non Operating Income (Expenses) | -8.07 | -0.57 | -0.19 | -0.16 | 2.25 | -0.14 |
EBT Excluding Unusual Items | 43.82 | 31.43 | 16.37 | -20.37 | -7.35 | -25.02 |
Gain (Loss) on Sale of Investments | 7.34 | 7.53 | 11.43 | 12.19 | 1.08 | -2.88 |
Gain (Loss) on Sale of Assets | -0.06 | 0.7 | -0.11 | -0.04 | 0.02 | - |
Asset Writedown | -2.69 | - | - | - | -0.08 | -0.12 |
Other Unusual Items | 10.13 | 11.69 | 24.44 | 13.83 | 9.3 | 16.05 |
Pretax Income | 58.54 | 51.34 | 52.13 | 5.61 | 2.97 | -11.97 |
Income Tax Expense | 0.04 | 0.26 | 0.06 | -0.08 | -0.1 | - |
Net Income | 58.5 | 51.08 | 52.07 | 5.69 | 3.07 | -11.97 |
Net Income to Common | 58.5 | 51.08 | 52.07 | 5.69 | 3.07 | -11.97 |
Net Income Growth | -13.62% | -1.90% | 815.36% | 85.17% | - | - |
Shares Outstanding (Basic) | 471 | 471 | 471 | 470 | 421 | 400 |
Shares Outstanding (Diluted) | 471 | 471 | 471 | 470 | 421 | 400 |
Shares Change | -0.10% | 0.00% | 0.14% | 11.71% | 5.08% | 4.62% |
EPS (Basic) | 0.12 | 0.11 | 0.11 | 0.01 | 0.01 | -0.03 |
EPS (Diluted) | 0.12 | 0.11 | 0.11 | 0.01 | 0.01 | -0.03 |
EPS Growth | -13.53% | -1.90% | 814.05% | 65.75% | - | - |
Additional Metrics
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Free Cash Flow | -23.94 | -31.33 | 23.52 | -79.9 | -41.31 | -16.02 |
Free Cash Flow Per Share | -0.05 | -0.07 | 0.05 | -0.17 | -0.10 | -0.04 |
Dividend Per Share | 0.021 | 0.021 | - | - | - | - |
Dividend Growth | - | - | - | - | - | - |
Gross Margin | 55.56% | 57.25% | 58.01% | 63.35% | 68.83% | 72.06% |
Operating Margin | 5.04% | 4.52% | 1.06% | -11.08% | -6.53% | -16.77% |
Profit Margin | 11.34% | 11.00% | 12.60% | 1.73% | 1.18% | -6.30% |
Free Cash Flow Margin | -4.64% | -6.74% | 5.69% | -24.27% | -15.87% | -8.43% |
EBITDA | 60.48 | 51.54 | 33.04 | -15.22 | -3.68 | -21.05 |
EBITDA Margin | 11.72% | 11.09% | 8.00% | -4.62% | -1.41% | -11.07% |
D&A For EBITDA | 34.46 | 30.56 | 28.66 | 21.26 | 13.31 | 10.82 |
EBIT | 26.01 | 20.98 | 4.38 | -36.48 | -16.99 | -31.86 |
EBIT Margin | 5.04% | 4.52% | 1.06% | -11.08% | -6.53% | -16.77% |
Effective Tax Rate | 0.07% | 0.51% | 0.11% | - | - | - |
Revenue as Reported | 240.78 | 464.53 | 413.17 | 329.19 | 260.32 | 190.03 |